2,6-Diaminopurine

2,6-Diaminopurine

SCHEMBL9220451

Nc1nc(N)c2[nH]cnc2n1.O=C1CCCN1

nearest known ligand 0.64

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDPK1 O15530 1/20 0.64
▸ GDA Q9Y2T3 1/20 0.64
▸ DPP4 P27487 1/20 0.49
▸ CDK2 P24941 9/20 0.45
▸ MAP3K5 Q99683 2/20 0.42
▸ OR51E2 Q9H255 1/20 0.42
▸ CDK1 P06493 8/20 0.41
▸ CCNB1 P14635 8/20 0.41
▸ CCNA2 P20248 8/20 0.41
▸ CCNA1 P78396 8/20 0.41
▸ MGMT P16455 5/20 0.41
▸ PNP P00491 1/20 0.41
▸ CCNB2 O95067 1/20 0.40
▸ MAPK3 P27361 1/20 0.40
▸ CLK1 P49759 1/20 0.40
▸ CDK5 Q00535 1/20 0.40
▸ PIN1 Q13526 1/20 0.40
▸ CCNB3 Q8WWL7 1/20 0.40
▸ HRH4 Q9H3N8 1/20 0.40
▸ LMNA P02545 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
6-Chloroguanine SCHEMBL9226302 0.88 DPP4 (0.68) PDPK1GDADPP4CDK2MAP3K5
2,6-Diaminopurine SCHEMBL22775220 0.81 PDPK1 (0.60) PDPK1GDADPP4CDK2MAP3K5
2,6-Diaminopurine SCHEMBL24053 0.80 PDPK1 (1.00) PDPK1GDADPP4CDK2MAP3K5
Guanine SCHEMBL9220514 0.80 PNP (0.70) GDADPP4OR51E2PNP
2,6-Diaminopurine SCHEMBL28206545 0.78 PDPK1 (0.96) PDPK1GDADPP4CDK2MAP3K5
2,6-Diaminopurine SCHEMBL8757979 0.78 PDPK1 (0.96) PDPK1GDADPP4CDK2MAP3K5
2,6-Diaminopurine SCHEMBL27891733 0.78 PDPK1 (0.96) PDPK1GDADPP4CDK2MAP3K5
2,6-Diaminopurine SCHEMBL9220440 0.78 OR51E2 (0.42) PDPK1GDAOR51E2ADORA2A
2,6-Diaminopurine SCHEMBL29143272 0.77 PDPK1 (0.92) PDPK1GDADPP4CDK2MAP3K5
2,6-Diaminopurine SCHEMBL9424492 0.77 PDPK1 (0.72) PDPK1GDADPP4CDK2MAP3K5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0215942-B1 POLYNUCLEOTIDE ASSAY REAGENT AND METHOD ANTIVIRALS INC (US) 1995-07-12 — — EP disclosed
EP-0639582-A2 Polynucleotide assay reagent and method ANTIVIRALS INC. (US) 1995-02-22 — — EP disclosed
US-5217866-A Polynucleotide assay reagent and method ANTI-GENE DEVELOPMENT GROUP (US) 1993-06-08 — — US disclosed
EP-0216860-B1 STEREOREGULAR POLYNUCLEOTIDE-BINDING POLYMERS SUMMERTON, James (US) 1992-10-28 — — EP disclosed
EP-0216860-A4 STEREOREGULAR POLYNUCLEOTIDE-BINDING POLYMERS. SUMMERTON JAMES (US) 1989-02-22 — — EP disclosed
EP-0215942-A4 POLYNUCLEOTIDE ASSAY REAGENT AND METHOD. SUMMERTON JAMES 1988-08-23 — — EP disclosed
EP-0216860-A1 STEREOREGULAR POLYNUCLEOTIDE-BINDING POLYMERS. SUMMERTON JAMES (US) 1987-04-08 — — EP disclosed
EP-0215942-A1 POLYNUCLEOTIDE ASSAY REAGENT AND METHOD. SUMMERTON JAMES 1987-04-01 — — EP disclosed
WO-1986005518-A1 STEREOREGULAR POLYNUCLEOTIDE-BINDING POLYMERS SUMMERTON JAMES 1986-09-25 — — WO disclosed
WO-1986005519-A1 POLYNUCLEOTIDE ASSAY REAGENT AND METHOD SUMMERTON JAMES 1986-09-25 — — WO disclosed
Send feedback